Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.

ConditionsFluid Overload Glomerulosclerosis, Focal Segmental Edema Membranous Nephropathy Minimal Change Disease Minimal Change Nephrotic Syndrome IgM Nephropathy Nephrotic Syndrome Glomerular Disease Nephrotic Syndrome, Minimal Change Nephrotic Syndrome in Children Nephrotic Syndrome With Edema (Diagnosis)FSGS

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age2+

SponsorUniversity of Michigan

About this trial

Researchers from the University of Michigan and Northwestern University are studying people's experiences with swelling caused by Nephrotic Syndrome. Interviews with patients (child and adult) and parents of young children will be conducted. The information collected from the interviews will be used to develop a survey to use when testing new medications for Nephrotic Syndrome.

Please consider participating in a 1-hour long interview with the Prepare-NS research study to discuss children and adults experiences with swelling.

Eligibility criteria

Qualifiers

Parents/guardians must be able to read and understand English;

Parents/guardians must be caring for a child (ages 2-11.999) with a medically documented diagnosis of idiopathic (primary) Nephrotic Syndrome (NS) or primary or monogenic NS associated kidney disease. Populations with Primary NS Conditions: Focal segmental glomerulosclerosis (FSGS), Minimal Change Disease (MCD), Immunoglobulin M (IgM) Nephropathy, Membranous Nephropathy (MN), and childhood - onset nephrotic syndrome not biopsied;

The child must have a current NS-associated edema

The child must have native kidney function

Disqualifiers

≥8 years of age

Able to read and understand English

Primary (idiopathic) kidney disease that causes NS or monogenic NS associated kidney disease.

Current NS-associated edema

Trial design

Treatments tested in this trial

Interview

Treatment groups

150 Participants

are divided into 2 treatment groups

Sponsors and collaborators

University of Michigan

Lead sponsor

Northwestern University

Collaborator

Food and Drug Administration (FDA)

Collaborator

Source ClinicalTrials.gov